ELF5 is a respiratory epithelial cell-specific risk gene for severe COVID-19
Maik Pietzner, Robert Lorenz Chua, Eleanor Wheeler, Katharina Jechow, Helena Radbruch, Saskia Trump, Bettina Heidecker, Frank L. Heppner, Roland Eils, Marcus A. Mall, Leif-Erik Sander, Irina Lehmann, Sören Lukassen, Nick Wareham, Christian Conrad, Claudia Langenberg
doi: https://doi.org/10.1101/2022.01.17.22269283
Maik Pietzner
1Computational Medicine, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Germany
2MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
Robert Lorenz Chua
3Center for Digital Health, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Germany
Eleanor Wheeler
2MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
Katharina Jechow
3Center for Digital Health, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Germany
Helena Radbruch
4Department of Neuropathology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Berlin, Germany
Saskia Trump
5Molecular Epidemiology Unit, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health (BIH), Berlin, Germany
Bettina Heidecker
6Department of Cardiology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Berlin, Germany
Frank L. Heppner
4Department of Neuropathology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Berlin, Germany
7Cluster of Excellence, NeuroCure, Berlin, Germany
8German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany
Roland Eils
3Center for Digital Health, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Germany
9Health Data Science Unit, Heidelberg University Hospital and BioQuant, Heidelberg, Germany
10German Center for Lung Research (DZL), associated partner site, Augustenburger Platz 1, 13353 Berlin, Germany
Marcus A. Mall
10German Center for Lung Research (DZL), associated partner site, Augustenburger Platz 1, 13353 Berlin, Germany
11Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
12Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
Leif-Erik Sander
13Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany
Irina Lehmann
5Molecular Epidemiology Unit, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health (BIH), Berlin, Germany
10German Center for Lung Research (DZL), associated partner site, Augustenburger Platz 1, 13353 Berlin, Germany
Sören Lukassen
3Center for Digital Health, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Germany
Nick Wareham
2MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
Christian Conrad
3Center for Digital Health, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Germany
Claudia Langenberg
1Computational Medicine, Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, Germany
2MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
Posted January 19, 2022.
ELF5 is a respiratory epithelial cell-specific risk gene for severe COVID-19
Maik Pietzner, Robert Lorenz Chua, Eleanor Wheeler, Katharina Jechow, Helena Radbruch, Saskia Trump, Bettina Heidecker, Frank L. Heppner, Roland Eils, Marcus A. Mall, Leif-Erik Sander, Irina Lehmann, Sören Lukassen, Nick Wareham, Christian Conrad, Claudia Langenberg
medRxiv 2022.01.17.22269283; doi: https://doi.org/10.1101/2022.01.17.22269283
ELF5 is a respiratory epithelial cell-specific risk gene for severe COVID-19
Maik Pietzner, Robert Lorenz Chua, Eleanor Wheeler, Katharina Jechow, Helena Radbruch, Saskia Trump, Bettina Heidecker, Frank L. Heppner, Roland Eils, Marcus A. Mall, Leif-Erik Sander, Irina Lehmann, Sören Lukassen, Nick Wareham, Christian Conrad, Claudia Langenberg
medRxiv 2022.01.17.22269283; doi: https://doi.org/10.1101/2022.01.17.22269283
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2780)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12430)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4297)
- Geriatric Medicine (397)
- Health Economics (705)
- Health Informatics (2776)
- Health Policy (1029)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (406)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4072)
- Nursing (218)
- Nutrition (603)
- Oncology (2150)
- Ophthalmology (608)
- Orthopedics (252)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (79)
- Pathology (480)
- Pediatrics (1152)
- Primary Care Research (473)
- Public and Global Health (6677)
- Radiology and Imaging (1457)
- Respiratory Medicine (889)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)